Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report
Siu-Yin Chan1, Ronnie T Poon, Kelvin K Ng
1Centre for the Study of Liver Disease and Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong, China.
World Journal of Gastroenterology
|May 27, 2005
Abstract:
Surgical resection with a tumor-free margin is the only curative treatment for hilar cholangiocarcinoma (Klatskin tumor). However, over half of the patients present late with unresectable tumors. Radiotherapy using external beam irradiation or intraluminal brachytherapy (ILBT) has been used to treat unresectable hilar cholangiocarcinoma with satisfactory outcome. We reported a patient with unresectable hilar cholangiocarcinoma surviving more than 6 years after combined external beam irradiation and ILBT.